In the News
In a study published in the August 12th edition of the New England Journal of Medicine, the Pediatric BMT team of Dr. John Wagner, Director, and Dr. Jakub Tolar, reported the amazing results from their first BMT clinical trial to treat Epidermolysis Bullosa (EB), a rare, genetic skin disease.
Director of the Division of Pediatric Hematology-Oncology and Blood and Marrow Transplantation
Dr. John E. Wagner is quoted in the Oncology Times, commenting on a recent article he published on the use of umbilical cord blood for transplantation: "Based on the fact that leukemia-free survival rates are similar with HLA mismatched UCB, we no longer have to think of UCB as a second-line source [of stem cells]."
Click here to read the full article.
New research by
Dr. Michael Verneris shows that transfusion of two rather than one unit of partially HLA-matched umbilical cord blood (UCB) appears to reduce the risk of relapse in leukemia patients in first or second complete remission.
University of Minnesota Amplatz Children's Hospital cited by U.S. News & World Report
Study findings may offer hope to more leukemia patients that they may live cancer-free.
The Best Doctors in America® database for 2009-2010 honors the top 5 percent of doctors in the nation, selected by their peers.
8-year-old Patrick received a celebratory send-off from law enforcement officers and firefighters before heading home to New York after BMT treatment.
A family moves to Minnesota in search of BMT treatment for their son who has a rare condition called IPEX.